All lobbying filings

BLUEBIRD STRATEGIES

BLUEBIRD STRATEGIES filed a Q1 report for CELLTRION USA, INC. on April 6, 2026.

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

All filings by BLUEBIRD STRATEGIES · Everything CELLTRION USA, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 6, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.